A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study
Public ClinicalTrials.gov record NCT00959647. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Extension Study of GDC-0449 (Hedgehog Pathway Inhibitor) in Patients Treated With GDC-0449 in a Previous Genentech-sponsored Phase I or Phase II Cancer Study
Study identification
- NCT ID
- NCT00959647
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Genentech, Inc.
- Industry
- Enrollment
- 19 participants
Conditions and interventions
Interventions
- Bevacizumab Drug
- FOLFIRI Drug
- FOLFOX Drug
- Vismodegib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2, 2009
- Primary completion
- Jan 8, 2014
- Completion
- Jan 8, 2014
- Last update posted
- May 7, 2026
2009 – 2014
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TGen Clinical Research Srvs | Scottsdale | Arizona | 85258 | — |
| Children's Hospital | Oakland | California | 94609 | — |
| Comprehensive Cancer Care | Palm Springs | California | 92262 | — |
| Stanford Univ Medical Center | Stanford | California | 94305 | — |
| Johns Hopkins Univ Med Center | Baltimore | Maryland | 21231 | — |
| University Of Michigan | Ann Arbor | Michigan | 48109-0934 | — |
| Karmanos Cancer Institute.. | Detroit | Michigan | 48201 | — |
| Nevada Cancer Research Foundation | Las Vegas | Nevada | 89169 | — |
| Irfan Firdaus, D.O. | Cincinnati | Ohio | 45242 | — |
| DermSurgery Associates, PA | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00959647, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00959647 live on ClinicalTrials.gov.